Everoflex is a unique combination of the everolimus, the proven drug and a blend of three biodegradable polymers and has been extensively tested in the “Supra” range of products. The unique blending of biodegradable polymers makes it more durable and very thin (just 4 – 6 microns in thickness) and at the same time helps it achieve a precise drug release, thus ensure safety and efficacy of the PCI procedure for the patient.
Unique ultrathin strut thickness of 60µ with L605 cobalt- chromium platform resulting in lower crimped profile, better crossability and open cell design with ‘S-Link’ providing unmatched flexibility and trackability without compromising radial strength.
Everoflex – Release Kinetics
- Designed to release drug at a sustained rate
- Nearly 80% of the drug is released in 4 weeks
- Remaining drug is programmed to get released at a slow rate for about 3 months
Everoflex has a sustained drug release pattern, which improves the overall safety, while maintaining the efficacy Drug Dose : 1.0 µg/mm2